Do not use for initial prostate cancer screening; preferred test is total prostate specific (PSA) antigen (0070121
) in conjunction with digital rectal exam (DRE). May be useful in distinguishing cancer from benign conditions in patients with mildly elevated total PSA and negative DRE.
Quantitative Electrochemiluminescent Immunoassay
This test is New York DOH approved.
- Patient Preparation
- Plasma separator tube or serum separator tube. Also acceptable: Plain red, green (sodium or lithium heparin), lavender (EDTA), or pink (K2EDTA).
- Specimen Preparation
- Allow specimen to clot completely at room temperature. Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)
- Storage/Transport Temperature
- Unacceptable Conditions
- Grossly hemolyzed specimens. Vaginal washings.
- After separation from cells: Ambient: 8 hours; Refrigerated: 48 hours; Frozen: 3 months
Refer to report.
| ||Prostate Specific Antigen, Total
| ||Prostate Specific Antigen, Free
| ||Prostate Specific Antigen Percent Free
If PSA Total is between 3.0-10.0 ng/mL, then Free PSA testing will be added. Additional charges apply.
The Free PSA percentage is calculated using results of the Total and Free PSA tests.
84153; if reflexed, add 84154
|Component Test Code*||Component Chart Name|
|0080286||Prostate Specific Antigen, Reflex|
|0080287||Prostate Specific Antigen, Free, Reflex|
|0080288||Prostate Specific Antigen-Pct Free, Rflx|
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
- Free PSA
- Free Ratio Reflex
- PSA Free/Total Ratio
- PSA ratio
- PSA Total
- PSA Total and Free
- Total PSA